Literature DB >> 28861905

Treatable inherited rare movement disorders.

H A Jinnah1, Alberto Albanese2,3, Kailash P Bhatia4, Francisco Cardoso5, Gustavo Da Prat6,7, Tom J de Koning8, Alberto J Espay9, Victor Fung10, Pedro J Garcia-Ruiz11, Oscar Gershanik12, Joseph Jankovic13, Ryuji Kaji14, Katya Kotschet15, Connie Marras16, Janis M Miyasaki17, Francesca Morgante18, Alexander Munchau19, Pramod Kumar Pal20, Maria C Rodriguez Oroz21,22,23,24, Mayela Rodríguez-Violante25, Ludger Schöls26,27, Maria Stamelou28,29, Marina Tijssen30, Claudia Uribe Roca31, Andres de la Cerda32, Emilia M Gatto33.   

Abstract

There are many rare movement disorders, and new ones are described every year. Because they are not well recognized, they often go undiagnosed for long periods of time. However, early diagnosis is becoming increasingly important. Rapid advances in our understanding of the biological mechanisms responsible for many rare disorders have enabled the development of specific treatments for some of them. Well-known historical examples include Wilson disease and dopa-responsive dystonia, for which specific and highly effective treatments have life-altering effects. In recent years, similarly specific and effective treatments have been developed for more than 30 rare inherited movement disorders. These treatments include specific medications, dietary changes, avoidance or management of certain triggers, enzyme replacement therapy, and others. This list of treatable rare movement disorders is likely to grow during the next few years because a number of additional promising treatments are actively being developed or evaluated in clinical trials.
© 2017 International Parkinson and Movement Disorder Society. © 2017 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Rare disease; experimental therapeutics; inherited disease; orphan disease; treatment

Mesh:

Year:  2017        PMID: 28861905      PMCID: PMC5921079          DOI: 10.1002/mds.27140

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  85 in total

1.  Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis.

Authors:  D Zolotov; S Wagner; K Kalb; J Bunia; A Heibges; R Klingel
Journal:  J Clin Apher       Date:  2012-01-20       Impact factor: 2.821

2.  Red flags for multiple system atrophy.

Authors:  Martin Köllensperger; Felix Geser; Klaus Seppi; Michaela Stampfer-Kountchev; Martin Sawires; Christoph Scherfler; Sylvia Boesch; Joerg Mueller; Vasiliki Koukouni; Niall Quinn; Maria Teresa Pellecchia; Paolo Barone; Nicole Schimke; Richard Dodel; Wolfgang Oertel; Erik Dupont; Karen Østergaard; Christine Daniels; Günther Deuschl; Tanya Gurevich; Nir Giladi; Miguel Coelho; Cristina Sampaio; Christer Nilsson; Håkan Widner; Francesca Del Sorbo; Alberto Albanese; Adriana Cardozo; Eduardo Tolosa; Michael Abele; Thomas Klockgether; Christoph Kamm; Thomas Gasser; Ruth Djaldetti; Carlo Colosimo; Giuseppe Meco; Anette Schrag; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2008-06-15       Impact factor: 10.338

3.  Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.

Authors:  Michèl A Willemsen; Marcel M Verbeek; Erik-Jan Kamsteeg; Johanneke F de Rijk-van Andel; Alec Aeby; Nenad Blau; Alberto Burlina; Maria A Donati; Ben Geurtz; Padraic J Grattan-Smith; Martin Haeussler; Georg F Hoffmann; Hans Jung; Johannis B de Klerk; Marjo S van der Knaap; Fernando Kok; Vincenzo Leuzzi; Pascale de Lonlay; Andre Megarbane; Hugh Monaghan; Willy O Renier; Pierre Rondot; Monique M Ryan; Jürgen Seeger; Jan A Smeitink; Gerry C Steenbergen-Spanjers; Evangeline Wassmer; Bernhard Weschke; Frits A Wijburg; Bridget Wilcken; Dimitrios I Zafeiriou; Ron A Wevers
Journal:  Brain       Date:  2010-04-29       Impact factor: 13.501

Review 4.  Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach.

Authors:  Davide Tonduti; Luisa Chiapparini; Isabella Moroni; Anna Ardissone; Giovanna Zorzi; Federica Zibordi; Sergio Raspante; Celeste Panteghini; Barbara Garavaglia; Nardo Nardocci
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

Review 5.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

6.  A series of pregnancies in women with inherited metabolic disease.

Authors:  Janneke G Langendonk; Jonathan C P Roos; Lindsay Angus; Monique Williams; François P J Karstens; Johannes B C de Klerk; Charlé Maritz; Tawfeg Ben-Omran; Catherine Williamson; Robin H Lachmann; Elaine Murphy
Journal:  J Inherit Metab Dis       Date:  2011-09-15       Impact factor: 4.982

7.  Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone.

Authors:  Brahim Tabarki; Majid Alfadhel; Saad AlShahwan; Khaled Hundallah; Shatha AlShafi; Amel AlHashem
Journal:  Eur J Paediatr Neurol       Date:  2015-06-12       Impact factor: 3.140

8.  Clinical research for rare disease: opportunities, challenges, and solutions.

Authors:  Robert C Griggs; Mark Batshaw; Mary Dunkle; Rashmi Gopal-Srivastava; Edward Kaye; Jeffrey Krischer; Tan Nguyen; Kathleen Paulus; Peter A Merkel
Journal:  Mol Genet Metab       Date:  2008-11-13       Impact factor: 4.797

Review 9.  Enzyme replacement and substrate reduction therapy for Gaucher disease.

Authors:  Elad Shemesh; Laura Deroma; Bruno Bembi; Patrick Deegan; Carla Hollak; Neal J Weinreb; Timothy M Cox
Journal:  Cochrane Database Syst Rev       Date:  2015-03-27

10.  Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes.

Authors:  Kalliopi Sofou; Maria Dahlin; Tove Hallböök; Marie Lindefeldt; Gerd Viggedal; Niklas Darin
Journal:  J Inherit Metab Dis       Date:  2017-01-18       Impact factor: 4.982

View more
  19 in total

Review 1.  Principles of Medical and Surgical Treatment of Cerebral Palsy.

Authors:  Eric M Chin; Hilary E Gwynn; Shenandoah Robinson; Alexander H Hoon
Journal:  Neurol Clin       Date:  2020-05       Impact factor: 3.806

Review 2.  Medical and Surgical Treatments for Dystonia.

Authors:  H A Jinnah
Journal:  Neurol Clin       Date:  2020-03-02       Impact factor: 3.806

Review 3.  Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features.

Authors:  Serena Galosi; Francesca Nardecchia; Vincenzo Leuzzi
Journal:  Mov Disord Clin Pract       Date:  2020-02-04

4.  Anderson-Fabry Disease: A Rare Cause of Levodopa-Responsive Early-Onset Parkinsonism.

Authors:  Ioana Cociasu; Chiara Sorbera; Antonino Tuttolomondo; Francesca Morgante
Journal:  Mov Disord Clin Pract       Date:  2021-09-03

Review 5.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 6.  Systematic clinical approach for diagnosing upper limb tremor.

Authors:  Jaron van de Wardt; A M Madelein van der Stouwe; Michiel Dirkx; Jan Willem J Elting; Bart Post; Marina Aj Tijssen; Rick C Helmich
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-05-26       Impact factor: 10.154

Review 7.  Genetic Dystonia-ataxia Syndromes: Clinical Spectrum, Diagnostic Approach, and Treatment Options.

Authors:  Malco Rossi; Bettina Balint; Patricio Millar Vernetti; Kailash P Bhatia; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2018-07-03

8.  The Spectrum of Movement Disorders in Childhood-Onset Lysosomal Storage Diseases.

Authors:  Darius Ebrahimi-Fakhari; Clara Hildebrandt; Peter E Davis; Lance H Rodan; Irina Anselm; Olaf Bodamer
Journal:  Mov Disord Clin Pract       Date:  2017-12-10

Review 9.  Childhood-onset hereditary spastic paraplegia and its treatable mimics.

Authors:  Darius Ebrahimi-Fakhari; Afshin Saffari; Phillip L Pearl
Journal:  Mol Genet Metab       Date:  2021-06-24       Impact factor: 4.797

10.  A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy.

Authors:  Shen-Yang Lim; Ai Huey Tan; Azlina Ahmad-Annuar; Susanne A Schneider; Ping Chong Bee; Jia Lun Lim; Norlisah Ramli; Mohamad Imran Idris
Journal:  J Mov Disord       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.